Efficacy and Safety of Noninvasive Intravesical Instillation of Onabotulinum Toxin-A for Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome: Systematic Review and Meta-analysis
- Authors
- Lee, Hyun Young; Doo, Seung Whan; Yang, Won Jae; Song, Yun Seob; Sun, Hwa Yeon; Nho, Eli Jongchan; Lee, Bora; Kim, Jae Heon
- Issue Date
- Mar-2019
- Publisher
- ELSEVIER SCIENCE INC
- Citation
- UROLOGY, v.125, pp 50 - 57
- Pages
- 8
- Journal Title
- UROLOGY
- Volume
- 125
- Start Page
- 50
- End Page
- 57
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/44873
- DOI
- 10.1016/j.urology.2018.11.037
- ISSN
- 0090-4295
1527-9995
- Abstract
- OBJECTIVE To investigate the efficacy and safety of noninvasive intravesical instillation of onabotulinum toxin-A (OBTX-A) through systematic review and meta-analysis. Recently, several studies of noninvasive intravesical instillation of OBTX-A have been published. However, its efficacy is not well validated yet compared to well-known efficacy of minimally invasive intravesical injection of OBTX-A. METHOD Systematic review and meta-analysis were performed to evaluate the efficacy of noninvasive intravesical instillation of OBTX-A in patients with overactive bladder and interstitial cystitis/bladder pain syndrome by measuring outcomes such as urgency episode per 72 hours, frequency per 72 hours, urgency urinary incontinence, voided volume (VV), postvoided residual volume, maximum flow rate, and patient perception of bladder condition. RESULT Six trials in 4 studies that compared instillation of OBTX-A and placebo involving 248 patients (121 experimental and 127 controls) were included for final data extraction. Instillation of OBTX-A significantly increased VV, with a mean difference of 38.48 (95% confidence interval: 76.05, 0.92) compared to the placebo group. However, other outcomes showed statistically insignificant changes. Major adverse events were not reported in the group receiving intravesical instillation of OBTX-A. CONCLUSION Intravesical instillation of OBTX-A showed limited efficacy with improvement of VV for treatment of overactive bladder or interstitial cystitis/bladder pain syndrome. More studies are needed to overcome the efficacy of current noninvasive bladder instillation of OBTX-A regarding effective drug transport. (c) 2018 Elsevier Inc.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Business & Economics > Department of Applied Statistics > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/44873)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.